Last updated: 4 months ago
Radiopharm Theranostics Report: Lantheus Boosts Shareholding with A$8M Placement
Radiopharm Theranostics Limited's Form 6-K highlights Lantheus's A$8M investment, signaling growth potential. Key compliance details and strategic insights for investors.